Allogeneic Marrow Grafting for Treatment of Aplastic Anemia
Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Paul E. Neiman(University of Washington), E.R. Giblett(Public Health – Seattle & King County), CD Buckner(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), R. A. Clift(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), A Fefer(University of Washington), E. Donnall Thomas(AbbVie (United States)), F L Johnson(University of Washington), K. G. Lerner(University of Washington), Harold Glucksberg(University of Washington)
Cited by 304
Related Papers
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k